VNRX - VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of Sidoti's Virtual Microcap Conference
VolitionRx Ltd. (NYSE American: VNRX) is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics TM, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics. For more information, visit the company's website at www.volition.com
To view IBN’s virtual coverage of VolitionRx Ltd. and other presenters at the Sidoti Microcap Conference, as well as gain access to additional conference information and registration, visit https://ibn.fm/SidotiMay2021Portal
Institutional, family office and high-net-worth investors, as well as RIAs, who wish to schedule a 1x1 meeting with the Company can contact the Sidoti conference team directly at conference@sidoti.com
To view IBN’s virtual coverage of the Sidoti Virtual Microcap Conference, visit https://ibn.fm/SidotiMay2021Portal
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at the Sidoti Virtual Microcap Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com